Routes to induced pluripotent stem cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Current Opinion in Genetics and Development

• Publication date

  2014-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.gde.2014.08.006PMID 25198100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Induction of pluripotency in human somatic cells via a transient state resembling primitive streak-like mesendoderm

  2014cited by this paper
• C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells

  2013cited by this paper
• High resolution analysis with novel cell-surface markers identifies routes to iPS cells

  2013cited by this paper
• Hierarchical mechanisms for direct reprogramming of fibroblasts to neurons.

  2013cited by this paper
• C/EBPα induces highly efficient macrophage transdifferentiation of B lymphoma and leukemia cell lines and impairs their tumorigenicity.

  2013cited by this paper
• H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs

  2012cited by this paper
• A late transition in somatic cell reprogramming requires regulators distinct from the pluripotency network.

  2012cited by this paper
• Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase.

  2012cited by this paper
• Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency.

  2012cited by this paper
• Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome.

  2012cited by this paper
• A molecular roadmap of reprogramming somatic cells into iPS cells.

  2012cited by this paper
• E‐cadherin is crucial for embryonic stem cell pluripotency and can replace OCT4 during somatic cell reprogramming

  2011cited by this paper
• MicroRNA Cluster 302–367 Enhances Somatic Cell Reprogramming by Accelerating a Mesenchymal-to-Epithelial Transition*

  2011cited by this paper
• Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells

  2011cited by this paper
• Direct reprogramming of mouse fibroblasts to neural progenitors

  2011cited by this paper
• Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy

  2011cited by this paper
• Direct conversion of human fibroblasts to multilineage blood progenitors

  2010cited by this paper
• Dynamic single-cell imaging of direct reprogramming reveals an early specifying event

  2010cited by this paper
• A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts.

  2010cited by this paper
• Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming.

  2010cited by this paper
• Elite and stochastic models for induced pluripotent stem cell generation

  2009cited by this paper
• A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog.

  2009cited by this paper
• The mysteries of induced pluripotency: where will they lead?

  2009cited by this paper
• Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells

  2009cited by this paper
• Direct cell reprogramming is a stochastic process amenable to acceleration

  2009cited by this paper
• Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

  2008cited by this paper
• Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

  2008cited by this paper
• Dissecting direct reprogramming through integrative genomic analysis

  2008cited by this paper
• Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

  2008cited by this paper
• Generation of germline-competent induced pluripotent stem cells

  2007cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4.

  2002cited by this paper
• Klf4 is a transcription factor required for establishing the barrier function of the skin

  1999cited by this paper

• Parkinson's disease: Present and future of cell therapy

  2022cites this paper
• Treatment of Parkinson’s Disease through Personalized Medicine and Induced Pluripotent Stem Cells

  2019cites this paper
• Personalized gene and cell therapy for Duchenne Muscular Dystrophy.

  2018cites this paper
• Time-course transcriptome analysis of human cellular reprogramming from multiple cell types reveals the drastic change occurs between the mid phase and the late phase

  2018cites this paper
• Perspectives of Parkinson ’ s Disease Therapies using Induced Pluripotent Stem Cells

  2018cites this paper
• Developing DamID-seq to investigate transcription factor binding in mammalian cells

  2017cites this paper
• Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming

  2017cites this paper
• Modeling Parkinson's disease with induced pluripotent stem cells harboring α‐synuclein mutations

  2017cites this paper
• Emerging Transcriptional Mechanisms in the Regulation of Epithelial to Mesenchymal Transition and Cellular Plasticity in the Kidney

  2016cites this paper
• Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis

  2016cites this paper
• Smad2/3 potentiate cell identity conversions with master transcription factors

  2016cites this paper
• Chromatin Accessibility and its Relationship to Pluripotency and the Induction of Pluripotent Stem Cells

  2015cites this paper
• Updating the Argument for Permitting and Federally Funding Stem Cell Research

  2015cites this paper
• Do circulating cells transdifferentiate and replenish stem cell pools in the brain and periphery?

  2015cites this paper
• Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.

  2015cites this paper
• The potential of induced pluripotent stem cells in models of neurological disorders: implications on future therapy

  2015cites this paper
• Tissue and Animal Models of Sudden Cardiac Death

  2015cites this paper
• Klf 4 and stem cell literatures

  2014cites this paper